Dario Tuccinardi on Obesity as Cardiovascular Treatment Target
Dario Tuccinardi, Assistant Professor in Endocrinology at The Bio-Medical University of Rome, shared on LinkedIn:
”Obesity is no longer just a cardiovascular risk factor. It is a cardiovascular treatment target.
Obesity and visceral adiposity actively shape cardiovascular disease, through inflammation, altered myocardial energetics, and diagnostic distortion.
Yet in daily practice, patients with obesity are still affected by clinical bias: symptoms are under-recognized, biomarkers misinterpreted, and treatment decisions delayed or diluted.
Our review argues for a double shift.
First: therapeutic.
Modern anti-obesity pharmacotherapy, especially GLP-1 receptor agonists and dual-incretin agents, extends beyond weight loss.
These drugs improve endothelial function, reduce inflammation, optimize myocardial metabolism, and now demonstrate cardiovascular event reduction even in people with obesity without diabetes.
Second: cultural and clinical.
Cardiologists must be supported in overcoming weight-related bias—moving beyond BMI, recognizing visceral obesity, correctly interpreting biomarkers, and confidently treating obesity as part of cardiovascular care rather than deferring it.
Treating obesity is no longer optional.
It is evidence-based cardiovascular medicine.
Weight loss is not about weight.
It’s about outcomes.”
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 19, 2026, 03:54Jennifer Trowbridge: How Mutant Blood Stem Cells Use Inflammation to Drive Their Own Expansion
-
Oct 19, 2026, 03:39Wyenona Hicks: Catching Up With Old Friends and New Colleagues at AABB 2026
-
Oct 19, 2026, 03:33Developing a Non-Invasive Treatment for Life-Threatening PE – University of Michigan College of Engineering
-
Oct 19, 2026, 03:28Jim Hoffman: How NETs Contribute to Gallstone Formation and Growth
-
Oct 19, 2026, 03:28Nicolas Hubacz: The Organized Chaos of Mitochondria
-
Oct 19, 2026, 03:02Neda Horvacki: Using ROTEM to Refine Transfusion Decisions in Acute Trauma
-
Oct 19, 2026, 02:45Diego Escarraman Martinez: MATTERs Study – When a Cohort Gave Us Major Clues about TXA in Trauma
-
Oct 19, 2026, 02:35Brian O Mahony: Promoting Physical Activity and Sport in Haemophilia Care
-
Oct 19, 2026, 02:35Malusi Mtetwa: Tranexamic Acid – What Does the Evidence Tell Us?